Delivery Order SPE2DB22D3501-SPE2DB24FXB90

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $51K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $100,466.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $9,897.94 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,626.77 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. This contract has an ultimate completion date of March 20, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,400.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICK medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract, valued at $57,321.41, to Amerisourcebergen Drug Corporation's Corporate Office division. This contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 22, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a $7,566.07 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SURECLICKML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a...
The Defense Logistics Agency (DLA) awarded a $9,482.29 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENBREL 50 MG/ML SURECLICK medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $30,084.55 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $19,410.24 firm-fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The delivery order has an ultimate completion date of October 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceuticals. The $12,601.23 contract has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXB90
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $51,462.68 firm fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of ENBREL 50 MG/ML SURECLICK syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a completion date of September 25, 2024 and does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical medications and medical commodities to various federal agencies and healthcare providers.

Generated 12/24/24, 9:39 AM